VBI Vaccines Inc (VBIV) is a Cambridge, MA biopharmaceutical company that develops treatments for infectious diseases and immuno-oncology. On March 31, they announced a collaboration with the National Research Council of Canada (NRC) to develop a pan-coronavirus vaccine targeting COVID-19, but can help with SARS and MERS as well. Roman Szumski, Vice President, Life Sciences […]